Author Question: A patient with infertility will begin taking menotropins Repronex. The nurse will evaluate this ... (Read 58 times)

Kthamas · **on:** Jul 23, 2018

A patient with infertility will begin taking menotropins Repronex. The nurse will evaluate this patient's history to determine whether the:

a. patient has a history of hyperinsulinemia.
b. patient has excessive prolactin secretion.
c. patient's pituitary can produce LH and FSH.
d. patient's ovaries are capable of responding to gonadotropins.

Question 2

A patient has been diagnosed with multiple sclerosis (MS) for 10 years and has a history of 3 periods of neurologic dysfunction lasting several weeks separated by long periods of full recov-ery.

In the past 6 months, the patient has had a prolonged period of neurologic dysfunction without remission. The nurse understands that the patient may have which MS subtype? a. Primary progressive MS
b. Progressive-relapsing MS
c. Relapsing-remitting MS
d. Secondary progressive MS

kbennett34 · **Reply #1 on:** Jul 23, 2018

Answer to Question 1

D
Menotropins are used when gonadotropin secretion by the pituitary is insufficient to provide adequate ovarian stimulation. Candidates must have ovaries capable of responding to FSH and LH. Metformin is used for hyperinsulinemia. Women with excessive prolactin secretion are treated with cabergoline. Menotropins contain equal amounts of LH and FSH and act directly on the ovaries, so the pituitary's inability to produce these hormones is not a factor for beginning treatment with this drug.

Answer to Question 2

D
Secondary progressive MS occurs when a patient with relapsing-remitting MS develops steadily worsening dysfunction with or without plateaus or acute exacerbations, or minor remissions. Within 10 to 20 years of onset, about 50 of patients with MS will develop this type. Primary progressive MS occurs when symptoms grow progressively more intense from the onset. Pro-gressive-relapsing MS is similar to primary progressive MS, but with acute exacerbations imposed on the steadily worsening symptoms. Relapsing-remitting MS is the most common initial presentation, which is characterized by recurrent, clearly defined episodes of symptoms with pe-riods of remission with relapse occurring approximately twice every 3 years.